Last reviewed · How we verify
K1-70 intramuscular or K1-70 intravenous
K1-70 intramuscular or K1-70 intravenous is a Small molecule drug developed by AV7 Limited. It is currently in Phase 1 development.
At a glance
| Generic name | K1-70 intramuscular or K1-70 intravenous |
|---|---|
| Sponsor | AV7 Limited |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- K1-70 intramuscular or K1-70 intravenous CI brief — competitive landscape report
- K1-70 intramuscular or K1-70 intravenous updates RSS · CI watch RSS
- AV7 Limited portfolio CI
Frequently asked questions about K1-70 intramuscular or K1-70 intravenous
What is K1-70 intramuscular or K1-70 intravenous?
K1-70 intramuscular or K1-70 intravenous is a Small molecule drug developed by AV7 Limited.
Who makes K1-70 intramuscular or K1-70 intravenous?
K1-70 intramuscular or K1-70 intravenous is developed by AV7 Limited (see full AV7 Limited pipeline at /company/av7-limited).
What development phase is K1-70 intramuscular or K1-70 intravenous in?
K1-70 intramuscular or K1-70 intravenous is in Phase 1.